International Patient Summary (IPS)
1.1.0-ballot - CI Build
International Patient Summary (IPS)
1.1.0-ballot - CI Build
International Patient Summary (IPS), published by Health Level Seven. This guide is not an authorized publication; it is the continuous build for version 1.1.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/CDA-IPS/ and changes regularly. See the Directory of published versions
| Draft as of 2024-08-19 |
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.11.22.2--20161206000000",
"meta" : {
"source" : "https://art-decor.org/ad/#/hl7ips-/terminology/valueset",
"profile" : [
🔗 "http://hl7.org/fhir/StructureDefinition/shareablevalueset"
],
"tag" : [
{
"system" : "http://hl7.org/fhir/FHIR-version",
"code" : "4.0.1"
}
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet 2.16.840.1.113883.11.22.2--20161206000000</b></p><a name=\"2.16.840.1.113883.11.22.2--20161206000000\"> </a><a name=\"hc2.16.840.1.113883.11.22.2--20161206000000\"> </a><a name=\"2.16.840.1.113883.11.22.2--20161206000000-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Information Source: <a href=\"https://art-decor.org/ad/#/hl7ips-/terminology/valueset\">https://art-decor.org/ad/#/hl7ips-/terminology/valueset</a></p><p style=\"margin-bottom: 0px\">Profile: <a href=\"http://hl7.org/fhir/R4/shareablevalueset.html\">Shareable ValueSet</a></p><p style=\"margin-bottom: 0px\">Tag: 4.0.1 (Details: FHIRVersion code 4.0.1 = ' 4.0.1 ', stated as ' null ')</p></div><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/6.0.2/CodeSystem-v3-ActCode.html\"><code>http://terminology.hl7.org/CodeSystem/v3-ActCode</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>Comments</b></td></tr><tr><td><a href=\"http://terminology.hl7.org/6.0.2/CodeSystem-v3-ActCode.html#v3-ActCode-OINT\">OINT</a></td><td>Allergy or Intolerance</td><td>Hypersensitivity resulting in an adverse reaction upon exposure to an agent.</td><td>Note: Hypersensitivity resulting in an adverse reaction upon exposure to an agent. </td></tr></table></li><li>Include these codes as defined in <code>urn:oid:2.16.840.1.113883.4.642.1.122</code><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Comments</b></td></tr><tr><td>allergy</td><td>Allergy</td><td>Note: A propensity for hypersensitivity reaction(s) to a substance. These reactions are most typically type I hypersensitivity, plus other "allergy-like" reactions, including pseudoallergy. </td></tr><tr><td>intolerance</td><td>Intolerance</td><td>Note: A propensity for adverse reactions to a substance that is not judged to be allergic or "allergy-like". These reactions are typically (but not necessarily) non-immune. They are to some degree idiosyncratic and/or individually specific (i.e. are not a reaction that is expected to occur with most or all patients given similar circumstances). </td></tr></table></li></ul></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod",
"valuePeriod" : {
"start" : "2016-12-06T00:00:00+02:00"
}
}
],
"url" : "http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.2--20161206000000",
"identifier" : [
{
"use" : "official",
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.11.22.2"
}
],
"version" : "1.1.0-ballot",
"name" : "AllergyOrIntollerance_VS",
"title" : "Allergy or Intolerance Type",
"status" : "draft",
"experimental" : false,
"date" : "2024-08-19T09:46:05+00:00",
"publisher" : "Health Level Seven",
"contact" : [
{
"name" : "HL7 International - International Patient Summary",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/structure"
}
]
}
],
"description" : "Allergy or Intolerance Type",
"immutable" : false,
"compose" : {
"include" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ActCode",
"concept" : [
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-concept-comments",
"valueString" : "Hypersensitivity resulting in an adverse reaction upon exposure to an agent."
}
],
"code" : "OINT",
"display" : "Allergy or Intolerance"
}
]
},
{
"system" : "urn:oid:2.16.840.1.113883.4.642.1.122",
"concept" : [
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-concept-comments",
"valueString" : "A propensity for hypersensitivity reaction(s) to a substance. These reactions are most typically type I hypersensitivity, plus other \"allergy-like\" reactions, including pseudoallergy."
}
],
"code" : "allergy",
"display" : "Allergy"
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-concept-comments",
"valueString" : "A propensity for adverse reactions to a substance that is not judged to be allergic or \"allergy-like\". These reactions are typically (but not necessarily) non-immune. They are to some degree idiosyncratic and/or individually specific (i.e. are not a reaction that is expected to occur with most or all patients given similar circumstances)."
}
],
"code" : "intolerance",
"display" : "Intolerance"
}
]
}
]
}
}
IG © 2024+ Health Level Seven. Package hl7.cda.uv.ips#1.1.0-ballot based on FHIR 4.0.1. Generated 2024-08-19
Links: Table of Contents |
QA Report
| Version History 
|
|
Propose a change